Review



streptavidin biosensors  (Sartorius AG)


Bioz Verified Symbol Sartorius AG is a verified supplier
Bioz Manufacturer Symbol Sartorius AG manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    Sartorius AG streptavidin biosensors
    Streptavidin Biosensors, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 98/100, based on 540 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biosensor/Octet+Streptavidin+(SA)+Biosensor/pm42900781-222-11-16
    Average 98 stars, based on 540 article reviews
    streptavidin biosensors - by Bioz Stars, 2026-11
    98/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Anti-IL31 antibodies for veterinary use
    Article Snippet: .. Over 100 ELISA positive clones were rescreened using biosensor (Forte Bio Octet). ..

    Clone Assay:

    Article Title: Anti-IL31 antibodies for veterinary use
    Article Snippet: .. Over 100 ELISA positive clones were rescreened using biosensor (Forte Bio Octet). ..

    Binding Assay:

    Article Title: Monoclonal antibody binding to TIGIT antigen, preparation method and use thereof
    Article Snippet: .. Biosensor (Fortebio-OCTET RED96, PALL Company) was used to in real-time monitor and determine the binding affinity and kinetic curves of the purified humanized 33D2 mAb to TIGIT antigen. ..

    Article Title: Highly Selective Aptamer-Molecularly Imprinted Polymer Hybrids for Recognition of SARS-CoV-2 Spike Protein Variants.
    Article Snippet: Cross-reactivity to the homologous SARS-CoV, and MERS-CoV (Sino Biological), was also assessed. .. Assessment of Aptamer Performance Using Bio-Layer Interferometry: The truncated SARS-CoV-2 binding aptamers were synthesized with a biotin modification at the 5′ terminus to allow subsequent conjugation to the streptavidin-coated biosensor (Octet Red 384, Sartorius, Germany). ..

    Article Title: Development of a Humanized Anti-Fibrotic Antibody Targeting Extracellular Collagen Assembly to Reduce Post-Traumatic Scarring
    Article Snippet: .. Binding kinetics for the ch4ACA (control) and 8 h1ACA variants selected from the initial 12 candidates based on EC 50 values of approximately 0.1 μg/ml were analyzed using an optical biosensor (Octet, Sartorius, Göttingen, Germany). ..

    Purification:

    Article Title: Monoclonal antibody binding to TIGIT antigen, preparation method and use thereof
    Article Snippet: .. Biosensor (Fortebio-OCTET RED96, PALL Company) was used to in real-time monitor and determine the binding affinity and kinetic curves of the purified humanized 33D2 mAb to TIGIT antigen. ..

    Software:

    Article Title: Advanced control strategies for continuous capture of monoclonal antibodies based upon biolayer interferometry.
    Article Snippet: .. The mAb breakthrough of the SMB capture process was specifically detected in the flow‐through by a continuous BLI prototype (Figure 2) using a biosensor with immobilized protein A (Octet ProA biosensor; Sartorius) and a customized software. ..

    Synthesized:

    Article Title: Highly Selective Aptamer-Molecularly Imprinted Polymer Hybrids for Recognition of SARS-CoV-2 Spike Protein Variants.
    Article Snippet: Cross-reactivity to the homologous SARS-CoV, and MERS-CoV (Sino Biological), was also assessed. .. Assessment of Aptamer Performance Using Bio-Layer Interferometry: The truncated SARS-CoV-2 binding aptamers were synthesized with a biotin modification at the 5′ terminus to allow subsequent conjugation to the streptavidin-coated biosensor (Octet Red 384, Sartorius, Germany). ..

    Modification:

    Article Title: Highly Selective Aptamer-Molecularly Imprinted Polymer Hybrids for Recognition of SARS-CoV-2 Spike Protein Variants.
    Article Snippet: Cross-reactivity to the homologous SARS-CoV, and MERS-CoV (Sino Biological), was also assessed. .. Assessment of Aptamer Performance Using Bio-Layer Interferometry: The truncated SARS-CoV-2 binding aptamers were synthesized with a biotin modification at the 5′ terminus to allow subsequent conjugation to the streptavidin-coated biosensor (Octet Red 384, Sartorius, Germany). ..

    Conjugation Assay:

    Article Title: Highly Selective Aptamer-Molecularly Imprinted Polymer Hybrids for Recognition of SARS-CoV-2 Spike Protein Variants.
    Article Snippet: Cross-reactivity to the homologous SARS-CoV, and MERS-CoV (Sino Biological), was also assessed. .. Assessment of Aptamer Performance Using Bio-Layer Interferometry: The truncated SARS-CoV-2 binding aptamers were synthesized with a biotin modification at the 5′ terminus to allow subsequent conjugation to the streptavidin-coated biosensor (Octet Red 384, Sartorius, Germany). ..

    other:

    Article Title: Immune memory shapes human polyclonal antibody responses to H2N2 vaccination
    Article Snippet: Biotinylated HA protein (A/New Caledonia/20/99, A/Michigan/45/2015, A/Indonesia/05/2005, A/Singapore/1/1957) at 5 μg/mL in assay buffer (PBS + 1% BSA), was loaded onto a PBS buffer equilibrated streptavidin-coated biosensor (Sartorius) for 300 seconds.

    Article Title: Immune memory shapes human polyclonal antibody responses to H2N2 vaccination
    Article Snippet: Biotinylated HA protein (A/New Caledonia/20/99, A/Michigan/45/2015, A/Indonesia/05/2005, A/Singapore/1/1957) at 5 μg/mL in assay buffer (PBS +1% BSA), was loaded onto a PBS buffer equilibrated streptavidin-coated biosensor (Sartorius) for 300 s. Biosensors were then equilibrated with assay buffer to remove unbound HA protein to establish a baseline signal for 15 s. Once the baseline was determined, HA protein bound biosensors were assigned to different concentrations of Fab (1600 nM, 400 nM, 100 nM, and 25 nM).

    Control:

    Article Title: Development of a Humanized Anti-Fibrotic Antibody Targeting Extracellular Collagen Assembly to Reduce Post-Traumatic Scarring
    Article Snippet: .. Binding kinetics for the ch4ACA (control) and 8 h1ACA variants selected from the initial 12 candidates based on EC 50 values of approximately 0.1 μg/ml were analyzed using an optical biosensor (Octet, Sartorius, Göttingen, Germany). ..



    Similar Products

    98
    Sartorius AG streptavidin biosensors
    Streptavidin Biosensors, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biosensor/Octet+Streptavidin+(SA)+Biosensor/pm42900781-222-11-16
    Average 98 stars, based on 1 article reviews
    streptavidin biosensors - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    96
    Sartorius AG octet anti-penta-his (his1k) biosensors
    Octet Anti Penta His (His1k) Biosensors, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biosensor/Octet+Anti-Penta-HIS+(HIS1K)+Biosensors/custom%40bio-layer-interferometry-his1k-biosensors%4042945275
    Average 96 stars, based on 1 article reviews
    octet anti-penta-his (his1k) biosensors - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    95
    Sartorius AG streptavidin coated sax2 biosensors
    TEDs were immobilized on the biosensor through the SpyTag003-SpyCatcher003 reaction. (A) Experimental procedure for the “Assay 1: Binding analysis” ( and ). Biotinylated SpyCatcher003 was immobilized on streptavidin-coated <t>SAX2</t> biosensors through the biotin-streptavidin interaction, followed by conjugation of SpyTag003-fused TED. (B) Experimental procedure for the “Assay 2: Covalent cross-linking analysis” ( and ). SpyCatcher003 was immobilized on AR2G biosensors through amine-coupling chemistry, followed by conjugation of SpyTag003-fused TED.
    Streptavidin Coated Sax2 Biosensors, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biosensor/Octet+High+Precision+Streptavidin+2%2E0+(SAX2)+Biosensors/pmc13685950-310-0-3
    Average 95 stars, based on 1 article reviews
    streptavidin coated sax2 biosensors - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Sartorius AG ar2g biosensors
    TEDs were immobilized on the biosensor through the SpyTag003-SpyCatcher003 reaction. (A) Experimental procedure for the “Assay 1: Binding analysis” ( and ). Biotinylated SpyCatcher003 was immobilized on streptavidin-coated SAX2 biosensors through the biotin-streptavidin interaction, followed by conjugation of SpyTag003-fused TED. (B) Experimental procedure for the “Assay 2: Covalent cross-linking analysis” ( and ). SpyCatcher003 was immobilized on <t>AR2G</t> biosensors through amine-coupling chemistry, followed by conjugation of SpyTag003-fused TED.
    Ar2g Biosensors, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biosensor/Octet+Amine+Reactive+2nd+Generation+(AR2G)+Biosensors/pmc13685950-321-21-23
    Average 95 stars, based on 1 article reviews
    ar2g biosensors - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Sartorius AG ar2g amine
    TEDs were immobilized on the biosensor through the SpyTag003-SpyCatcher003 reaction. (A) Experimental procedure for the “Assay 1: Binding analysis” ( and ). Biotinylated SpyCatcher003 was immobilized on streptavidin-coated SAX2 biosensors through the biotin-streptavidin interaction, followed by conjugation of SpyTag003-fused TED. (B) Experimental procedure for the “Assay 2: Covalent cross-linking analysis” ( and ). SpyCatcher003 was immobilized on <t>AR2G</t> biosensors through amine-coupling chemistry, followed by conjugation of SpyTag003-fused TED.
    Ar2g Amine, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biosensor/Octet+Amine+Reactive+2nd+Generation+(AR2G)+Biosensors/pm42900969-97-4-16
    Average 95 stars, based on 1 article reviews
    ar2g amine - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    96
    Sartorius AG octet high precision streptavidin sax biosensors
    TEDs were immobilized on the biosensor through the SpyTag003-SpyCatcher003 reaction. (A) Experimental procedure for the “Assay 1: Binding analysis” ( and ). Biotinylated SpyCatcher003 was immobilized on streptavidin-coated SAX2 biosensors through the biotin-streptavidin interaction, followed by conjugation of SpyTag003-fused TED. (B) Experimental procedure for the “Assay 2: Covalent cross-linking analysis” ( and ). SpyCatcher003 was immobilized on <t>AR2G</t> biosensors through amine-coupling chemistry, followed by conjugation of SpyTag003-fused TED.
    Octet High Precision Streptavidin Sax Biosensors, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biosensor/Octet+High+Precision+Streptavidin+(SAX)+Biosensors/pm42892450-41-0-10
    Average 96 stars, based on 1 article reviews
    octet high precision streptavidin sax biosensors - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Sartorius AG octet high precision streptavidin (sax) biosensors
    TEDs were immobilized on the biosensor through the SpyTag003-SpyCatcher003 reaction. (A) Experimental procedure for the “Assay 1: Binding analysis” ( and ). Biotinylated SpyCatcher003 was immobilized on streptavidin-coated SAX2 biosensors through the biotin-streptavidin interaction, followed by conjugation of SpyTag003-fused TED. (B) Experimental procedure for the “Assay 2: Covalent cross-linking analysis” ( and ). SpyCatcher003 was immobilized on <t>AR2G</t> biosensors through amine-coupling chemistry, followed by conjugation of SpyTag003-fused TED.
    Octet High Precision Streptavidin (Sax) Biosensors, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biosensor/Octet+High+Precision+Streptavidin+(SAX)+Biosensors/custom%40bio-layer-interferometry-sax-biosensors%4042892450
    Average 96 stars, based on 1 article reviews
    octet high precision streptavidin (sax) biosensors - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Sartorius AG anti penta his his1k biosensors
    (A) Fixed amino acid residues for MESSI-based deimmunization of LuxSit-i. The structure of LuxSit-i (shown in blue and red) with its luciferin substrate (shown in green) is generated by Alphafold-3. The color on LuxSit-i denotes the number of overlapping NMP-predicted HLA-DRB1*15:01 epitopes at each amino acid position. Fixed amino acid residues are depicted as yellow-colored spheres. (B) Sequence identity of MESSI-generated LuxSit-i variants relative to the parental LuxSit-i. (C) Structural metrics of MESSI-generated LuxSit-i variants. (D) Comparison of epitope density between parental LuxSit-i and a MESSI-generated variant, MESSI-D2. All structures were generated by AlphaFold-3. Color denotes the number of overlapping NMP-predicted HLA-DRB1*15:01 epitopes at each amino acid position. (E) Experimental validation of luminescence from MESSI-generated LuxSit-i variants. Gene fragments encoding the parental and MESSI-designed proteins were synthesized and used as linear DNA template for in vitro RNA transcription and protein translation (IVTT). Afterwards, the reaction product was purified with a nickel spin column to remove the His-tagged IVTT machinery. A final concentration of 25 µM of diphenylterazine (DTZ) was added to the purified proteins. Luminescence was recorded on a plate reader every minute over 2 hr. (F) Peak luminescence recorded within 2 hours after DTZ addition. “No template” denotes the negative control condition where no DNA template was added to the IVTT reaction. Error bars, standard deviation. n = 3 replicates. A two sided unpaired t-test with welch’s correction is calculated between no-target condition and each of the MESSI designs and parent. **, p < 0.01; ****, p < 0.0001. (G) Computational workflow for designing a deimmunized binder against PD-1 using MESSI coupled with BindCraft. In particular, MESSI is inserted at the end of the original BindCraft workflow to replace the soluble MPNN inverse folding model to design sequences against the optimized structures. (H) Structural metrics of MESSI-generated variants of anti-PD-1 binder. (I) Comparison of epitope density between the parental anti-PD-1 binder and a MESSI-generated variant, MESSI-D4. All structures were generated by AlphaFold-3. Blue colors denote a binder region that does not contain NMP predicted epitopes. Red color denotes binder regions with NMP-predicted HLA-DRB1*15:01 epitopes greater than 0. White color denotes the PD-1, the target protein for the designed binder. (J) Strep-tagged minibinders are produced with Genscript IVTT kit. After the production, the binders are purified with streptavidin beads and eluted in 1 mL of PBS. The dot plots show the concentration (expression) fold-change (FC) of the MESSI-generated binders relative to the parental binder designed by BindCraft. (K) Bio-Layer Interferometry (BLI) binding curves for measuring the binding parameters of MESSI-designed anti-PD-1 binders against the target PD-1 protein. The assay was performed at 30 °C and at 1,000 rpm. His-tagged PD-1 protein was firstly immobilized onto <t>HIS1K</t> biosensor on Octet RED384. Binders was applied at a concentration of 1 µM as an analyte for association and dissociation steps for 150 seconds and 30 seconds respectively. PA denotes the parent binder. (L) Equilibrium dissociation constant (K d ) of anti-PD-1 binder variants. K d was derived from the association (K a ) and dissociation (K dis ) rate constants measured from the five concentration scan BLI curves. Error bars represent the 95% confidence interval of the fitted K d . Differences in K d were assessed by a two-sided z-test using moving-block bootstrap standard errors of the global fit (85 seconds blocks, 1,000 resamples; Holm-corrected for comparisons). **, p<0.01
    Anti Penta His His1k Biosensors, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biosensor/Octet+Anti-Penta-HIS+(HIS1K)+Biosensors/bio_rxiv__64898__2026__10__09__758136-222-18-21
    Average 96 stars, based on 1 article reviews
    anti penta his his1k biosensors - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    99
    Cytiva Europe spr biosensor biacore 3000
    (A) Fixed amino acid residues for MESSI-based deimmunization of LuxSit-i. The structure of LuxSit-i (shown in blue and red) with its luciferin substrate (shown in green) is generated by Alphafold-3. The color on LuxSit-i denotes the number of overlapping NMP-predicted HLA-DRB1*15:01 epitopes at each amino acid position. Fixed amino acid residues are depicted as yellow-colored spheres. (B) Sequence identity of MESSI-generated LuxSit-i variants relative to the parental LuxSit-i. (C) Structural metrics of MESSI-generated LuxSit-i variants. (D) Comparison of epitope density between parental LuxSit-i and a MESSI-generated variant, MESSI-D2. All structures were generated by AlphaFold-3. Color denotes the number of overlapping NMP-predicted HLA-DRB1*15:01 epitopes at each amino acid position. (E) Experimental validation of luminescence from MESSI-generated LuxSit-i variants. Gene fragments encoding the parental and MESSI-designed proteins were synthesized and used as linear DNA template for in vitro RNA transcription and protein translation (IVTT). Afterwards, the reaction product was purified with a nickel spin column to remove the His-tagged IVTT machinery. A final concentration of 25 µM of diphenylterazine (DTZ) was added to the purified proteins. Luminescence was recorded on a plate reader every minute over 2 hr. (F) Peak luminescence recorded within 2 hours after DTZ addition. “No template” denotes the negative control condition where no DNA template was added to the IVTT reaction. Error bars, standard deviation. n = 3 replicates. A two sided unpaired t-test with welch’s correction is calculated between no-target condition and each of the MESSI designs and parent. **, p < 0.01; ****, p < 0.0001. (G) Computational workflow for designing a deimmunized binder against PD-1 using MESSI coupled with BindCraft. In particular, MESSI is inserted at the end of the original BindCraft workflow to replace the soluble MPNN inverse folding model to design sequences against the optimized structures. (H) Structural metrics of MESSI-generated variants of anti-PD-1 binder. (I) Comparison of epitope density between the parental anti-PD-1 binder and a MESSI-generated variant, MESSI-D4. All structures were generated by AlphaFold-3. Blue colors denote a binder region that does not contain NMP predicted epitopes. Red color denotes binder regions with NMP-predicted HLA-DRB1*15:01 epitopes greater than 0. White color denotes the PD-1, the target protein for the designed binder. (J) Strep-tagged minibinders are produced with Genscript IVTT kit. After the production, the binders are purified with streptavidin beads and eluted in 1 mL of PBS. The dot plots show the concentration (expression) fold-change (FC) of the MESSI-generated binders relative to the parental binder designed by BindCraft. (K) Bio-Layer Interferometry (BLI) binding curves for measuring the binding parameters of MESSI-designed anti-PD-1 binders against the target PD-1 protein. The assay was performed at 30 °C and at 1,000 rpm. His-tagged PD-1 protein was firstly immobilized onto <t>HIS1K</t> biosensor on Octet RED384. Binders was applied at a concentration of 1 µM as an analyte for association and dissociation steps for 150 seconds and 30 seconds respectively. PA denotes the parent binder. (L) Equilibrium dissociation constant (K d ) of anti-PD-1 binder variants. K d was derived from the association (K a ) and dissociation (K dis ) rate constants measured from the five concentration scan BLI curves. Error bars represent the 95% confidence interval of the fitted K d . Differences in K d were assessed by a two-sided z-test using moving-block bootstrap standard errors of the global fit (85 seconds blocks, 1,000 resamples; Holm-corrected for comparisons). **, p<0.01
    Spr Biosensor Biacore 3000, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biosensor/Biacore/bio_rxiv__64898__2026__10__14__759113-42-5-9
    Average 99 stars, based on 1 article reviews
    spr biosensor biacore 3000 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    97
    Sartorius AG ni nta biosensors
    (A) Fixed amino acid residues for MESSI-based deimmunization of LuxSit-i. The structure of LuxSit-i (shown in blue and red) with its luciferin substrate (shown in green) is generated by Alphafold-3. The color on LuxSit-i denotes the number of overlapping NMP-predicted HLA-DRB1*15:01 epitopes at each amino acid position. Fixed amino acid residues are depicted as yellow-colored spheres. (B) Sequence identity of MESSI-generated LuxSit-i variants relative to the parental LuxSit-i. (C) Structural metrics of MESSI-generated LuxSit-i variants. (D) Comparison of epitope density between parental LuxSit-i and a MESSI-generated variant, MESSI-D2. All structures were generated by AlphaFold-3. Color denotes the number of overlapping NMP-predicted HLA-DRB1*15:01 epitopes at each amino acid position. (E) Experimental validation of luminescence from MESSI-generated LuxSit-i variants. Gene fragments encoding the parental and MESSI-designed proteins were synthesized and used as linear DNA template for in vitro RNA transcription and protein translation (IVTT). Afterwards, the reaction product was purified with a nickel spin column to remove the His-tagged IVTT machinery. A final concentration of 25 µM of diphenylterazine (DTZ) was added to the purified proteins. Luminescence was recorded on a plate reader every minute over 2 hr. (F) Peak luminescence recorded within 2 hours after DTZ addition. “No template” denotes the negative control condition where no DNA template was added to the IVTT reaction. Error bars, standard deviation. n = 3 replicates. A two sided unpaired t-test with welch’s correction is calculated between no-target condition and each of the MESSI designs and parent. **, p < 0.01; ****, p < 0.0001. (G) Computational workflow for designing a deimmunized binder against PD-1 using MESSI coupled with BindCraft. In particular, MESSI is inserted at the end of the original BindCraft workflow to replace the soluble MPNN inverse folding model to design sequences against the optimized structures. (H) Structural metrics of MESSI-generated variants of anti-PD-1 binder. (I) Comparison of epitope density between the parental anti-PD-1 binder and a MESSI-generated variant, MESSI-D4. All structures were generated by AlphaFold-3. Blue colors denote a binder region that does not contain NMP predicted epitopes. Red color denotes binder regions with NMP-predicted HLA-DRB1*15:01 epitopes greater than 0. White color denotes the PD-1, the target protein for the designed binder. (J) Strep-tagged minibinders are produced with Genscript IVTT kit. After the production, the binders are purified with streptavidin beads and eluted in 1 mL of PBS. The dot plots show the concentration (expression) fold-change (FC) of the MESSI-generated binders relative to the parental binder designed by BindCraft. (K) Bio-Layer Interferometry (BLI) binding curves for measuring the binding parameters of MESSI-designed anti-PD-1 binders against the target PD-1 protein. The assay was performed at 30 °C and at 1,000 rpm. His-tagged PD-1 protein was firstly immobilized onto <t>HIS1K</t> biosensor on Octet RED384. Binders was applied at a concentration of 1 µM as an analyte for association and dissociation steps for 150 seconds and 30 seconds respectively. PA denotes the parent binder. (L) Equilibrium dissociation constant (K d ) of anti-PD-1 binder variants. K d was derived from the association (K a ) and dissociation (K dis ) rate constants measured from the five concentration scan BLI curves. Error bars represent the 95% confidence interval of the fitted K d . Differences in K d were assessed by a two-sided z-test using moving-block bootstrap standard errors of the global fit (85 seconds blocks, 1,000 resamples; Holm-corrected for comparisons). **, p<0.01
    Ni Nta Biosensors, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biosensor/Octet+Ni-NTA+(NTA)+Biosensors/pm42883724-205-9-7
    Average 97 stars, based on 1 article reviews
    ni nta biosensors - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    Image Search Results


    TEDs were immobilized on the biosensor through the SpyTag003-SpyCatcher003 reaction. (A) Experimental procedure for the “Assay 1: Binding analysis” ( and ). Biotinylated SpyCatcher003 was immobilized on streptavidin-coated SAX2 biosensors through the biotin-streptavidin interaction, followed by conjugation of SpyTag003-fused TED. (B) Experimental procedure for the “Assay 2: Covalent cross-linking analysis” ( and ). SpyCatcher003 was immobilized on AR2G biosensors through amine-coupling chemistry, followed by conjugation of SpyTag003-fused TED.

    Journal: Science Advances

    Article Title: Chemically encoded pH-tunable covalent adhesion by a bacterial thioester domain

    doi: 10.1126/sciadv.aeg7646

    Figure Lengend Snippet: TEDs were immobilized on the biosensor through the SpyTag003-SpyCatcher003 reaction. (A) Experimental procedure for the “Assay 1: Binding analysis” ( and ). Biotinylated SpyCatcher003 was immobilized on streptavidin-coated SAX2 biosensors through the biotin-streptavidin interaction, followed by conjugation of SpyTag003-fused TED. (B) Experimental procedure for the “Assay 2: Covalent cross-linking analysis” ( and ). SpyCatcher003 was immobilized on AR2G biosensors through amine-coupling chemistry, followed by conjugation of SpyTag003-fused TED.

    Article Snippet: Streptavidin-coated SAX2 biosensors (Sartorius) were hydrated for 10 min and loaded with 2 μM biotinylated SpyCatcher003-His-Avi for 5 min. To remove loosely bound proteins, the biosensors were regenerated using 10 mM glycine (pH 2.0).

    Techniques: Binding Assay, Analysis, Conjugation Assay, Covalent Coupling

    TEDs were immobilized on the biosensor through the SpyTag003-SpyCatcher003 reaction. (A) Experimental procedure for the “Assay 1: Binding analysis” ( and ). Biotinylated SpyCatcher003 was immobilized on streptavidin-coated SAX2 biosensors through the biotin-streptavidin interaction, followed by conjugation of SpyTag003-fused TED. (B) Experimental procedure for the “Assay 2: Covalent cross-linking analysis” ( and ). SpyCatcher003 was immobilized on AR2G biosensors through amine-coupling chemistry, followed by conjugation of SpyTag003-fused TED.

    Journal: Science Advances

    Article Title: Chemically encoded pH-tunable covalent adhesion by a bacterial thioester domain

    doi: 10.1126/sciadv.aeg7646

    Figure Lengend Snippet: TEDs were immobilized on the biosensor through the SpyTag003-SpyCatcher003 reaction. (A) Experimental procedure for the “Assay 1: Binding analysis” ( and ). Biotinylated SpyCatcher003 was immobilized on streptavidin-coated SAX2 biosensors through the biotin-streptavidin interaction, followed by conjugation of SpyTag003-fused TED. (B) Experimental procedure for the “Assay 2: Covalent cross-linking analysis” ( and ). SpyCatcher003 was immobilized on AR2G biosensors through amine-coupling chemistry, followed by conjugation of SpyTag003-fused TED.

    Article Snippet: SpyCatcher003 fused with an N-terminal 6×His (10 μM) was diluted 20-fold into 10 mM sodium acetate (pH 4.5) and immobilized onto AR2G biosensors (Sartorius) preactivated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide/sulfo– N -hydroxysuccinimide for 2 min. Unreacted esters were quenched with 1 M ethanolamine (pH 8.3).

    Techniques: Binding Assay, Analysis, Conjugation Assay, Covalent Coupling

    (A) Fixed amino acid residues for MESSI-based deimmunization of LuxSit-i. The structure of LuxSit-i (shown in blue and red) with its luciferin substrate (shown in green) is generated by Alphafold-3. The color on LuxSit-i denotes the number of overlapping NMP-predicted HLA-DRB1*15:01 epitopes at each amino acid position. Fixed amino acid residues are depicted as yellow-colored spheres. (B) Sequence identity of MESSI-generated LuxSit-i variants relative to the parental LuxSit-i. (C) Structural metrics of MESSI-generated LuxSit-i variants. (D) Comparison of epitope density between parental LuxSit-i and a MESSI-generated variant, MESSI-D2. All structures were generated by AlphaFold-3. Color denotes the number of overlapping NMP-predicted HLA-DRB1*15:01 epitopes at each amino acid position. (E) Experimental validation of luminescence from MESSI-generated LuxSit-i variants. Gene fragments encoding the parental and MESSI-designed proteins were synthesized and used as linear DNA template for in vitro RNA transcription and protein translation (IVTT). Afterwards, the reaction product was purified with a nickel spin column to remove the His-tagged IVTT machinery. A final concentration of 25 µM of diphenylterazine (DTZ) was added to the purified proteins. Luminescence was recorded on a plate reader every minute over 2 hr. (F) Peak luminescence recorded within 2 hours after DTZ addition. “No template” denotes the negative control condition where no DNA template was added to the IVTT reaction. Error bars, standard deviation. n = 3 replicates. A two sided unpaired t-test with welch’s correction is calculated between no-target condition and each of the MESSI designs and parent. **, p < 0.01; ****, p < 0.0001. (G) Computational workflow for designing a deimmunized binder against PD-1 using MESSI coupled with BindCraft. In particular, MESSI is inserted at the end of the original BindCraft workflow to replace the soluble MPNN inverse folding model to design sequences against the optimized structures. (H) Structural metrics of MESSI-generated variants of anti-PD-1 binder. (I) Comparison of epitope density between the parental anti-PD-1 binder and a MESSI-generated variant, MESSI-D4. All structures were generated by AlphaFold-3. Blue colors denote a binder region that does not contain NMP predicted epitopes. Red color denotes binder regions with NMP-predicted HLA-DRB1*15:01 epitopes greater than 0. White color denotes the PD-1, the target protein for the designed binder. (J) Strep-tagged minibinders are produced with Genscript IVTT kit. After the production, the binders are purified with streptavidin beads and eluted in 1 mL of PBS. The dot plots show the concentration (expression) fold-change (FC) of the MESSI-generated binders relative to the parental binder designed by BindCraft. (K) Bio-Layer Interferometry (BLI) binding curves for measuring the binding parameters of MESSI-designed anti-PD-1 binders against the target PD-1 protein. The assay was performed at 30 °C and at 1,000 rpm. His-tagged PD-1 protein was firstly immobilized onto HIS1K biosensor on Octet RED384. Binders was applied at a concentration of 1 µM as an analyte for association and dissociation steps for 150 seconds and 30 seconds respectively. PA denotes the parent binder. (L) Equilibrium dissociation constant (K d ) of anti-PD-1 binder variants. K d was derived from the association (K a ) and dissociation (K dis ) rate constants measured from the five concentration scan BLI curves. Error bars represent the 95% confidence interval of the fitted K d . Differences in K d were assessed by a two-sided z-test using moving-block bootstrap standard errors of the global fit (85 seconds blocks, 1,000 resamples; Holm-corrected for comparisons). **, p<0.01

    Journal: bioRxiv

    Article Title: Protein Deimmunization with a Generative Diffusion Model

    doi: 10.64898/2026.10.09.758136

    Figure Lengend Snippet: (A) Fixed amino acid residues for MESSI-based deimmunization of LuxSit-i. The structure of LuxSit-i (shown in blue and red) with its luciferin substrate (shown in green) is generated by Alphafold-3. The color on LuxSit-i denotes the number of overlapping NMP-predicted HLA-DRB1*15:01 epitopes at each amino acid position. Fixed amino acid residues are depicted as yellow-colored spheres. (B) Sequence identity of MESSI-generated LuxSit-i variants relative to the parental LuxSit-i. (C) Structural metrics of MESSI-generated LuxSit-i variants. (D) Comparison of epitope density between parental LuxSit-i and a MESSI-generated variant, MESSI-D2. All structures were generated by AlphaFold-3. Color denotes the number of overlapping NMP-predicted HLA-DRB1*15:01 epitopes at each amino acid position. (E) Experimental validation of luminescence from MESSI-generated LuxSit-i variants. Gene fragments encoding the parental and MESSI-designed proteins were synthesized and used as linear DNA template for in vitro RNA transcription and protein translation (IVTT). Afterwards, the reaction product was purified with a nickel spin column to remove the His-tagged IVTT machinery. A final concentration of 25 µM of diphenylterazine (DTZ) was added to the purified proteins. Luminescence was recorded on a plate reader every minute over 2 hr. (F) Peak luminescence recorded within 2 hours after DTZ addition. “No template” denotes the negative control condition where no DNA template was added to the IVTT reaction. Error bars, standard deviation. n = 3 replicates. A two sided unpaired t-test with welch’s correction is calculated between no-target condition and each of the MESSI designs and parent. **, p < 0.01; ****, p < 0.0001. (G) Computational workflow for designing a deimmunized binder against PD-1 using MESSI coupled with BindCraft. In particular, MESSI is inserted at the end of the original BindCraft workflow to replace the soluble MPNN inverse folding model to design sequences against the optimized structures. (H) Structural metrics of MESSI-generated variants of anti-PD-1 binder. (I) Comparison of epitope density between the parental anti-PD-1 binder and a MESSI-generated variant, MESSI-D4. All structures were generated by AlphaFold-3. Blue colors denote a binder region that does not contain NMP predicted epitopes. Red color denotes binder regions with NMP-predicted HLA-DRB1*15:01 epitopes greater than 0. White color denotes the PD-1, the target protein for the designed binder. (J) Strep-tagged minibinders are produced with Genscript IVTT kit. After the production, the binders are purified with streptavidin beads and eluted in 1 mL of PBS. The dot plots show the concentration (expression) fold-change (FC) of the MESSI-generated binders relative to the parental binder designed by BindCraft. (K) Bio-Layer Interferometry (BLI) binding curves for measuring the binding parameters of MESSI-designed anti-PD-1 binders against the target PD-1 protein. The assay was performed at 30 °C and at 1,000 rpm. His-tagged PD-1 protein was firstly immobilized onto HIS1K biosensor on Octet RED384. Binders was applied at a concentration of 1 µM as an analyte for association and dissociation steps for 150 seconds and 30 seconds respectively. PA denotes the parent binder. (L) Equilibrium dissociation constant (K d ) of anti-PD-1 binder variants. K d was derived from the association (K a ) and dissociation (K dis ) rate constants measured from the five concentration scan BLI curves. Error bars represent the 95% confidence interval of the fitted K d . Differences in K d were assessed by a two-sided z-test using moving-block bootstrap standard errors of the global fit (85 seconds blocks, 1,000 resamples; Holm-corrected for comparisons). **, p<0.01

    Article Snippet: Binding kinetics were measured by biolayer interferometry (BLI) on an Octet RED384 instrument (Sartorius, Cat. No. FB-20493) using anti-penta-HIS (HIS1K) biosensors (Sartorius, Cat. No. 18-5120) and tilted-bottom 384-well microplates (Sartorius, Cat. No. 18-5166).

    Techniques: Generated, Sequencing, Comparison, Variant Assay, Biomarker Discovery, Synthesized, In Vitro, Purification, Concentration Assay, Negative Control, Standard Deviation, Produced, Expressing, Binding Assay, Affinity Constant, Derivative Assay, Blocking Assay